Literature DB >> 24669362

SERPINE1: A Molecular Switch in the Proliferation-Migration Dichotomy in Wound-"Activated" Keratinocytes.

Tessa M Simone1, Craig E Higgins1, Ralf-Peter Czekay1, Brian K Law2, Stephen P Higgins1, Jaclyn Archambeault1, Stacie M Kutz3, Paul J Higgins1.   

Abstract

Significance: A highly interactive serine protease/plasmin/matrix metalloproteinase axis regulates stromal remodeling in the wound microenvironment. Current findings highlight the importance of stringent controls on protease expression and their topographic activities in cell proliferation, migration, and tissue homeostasis. Targeting elements in this cascading network may lead to novel therapeutic approaches for fibrotic diseases and chronic wounds. Recent Advances: Matrix-active proteases and their inhibitors orchestrate wound site tissue remodeling, cell migration, and proliferation. Indeed, the serine proteases urokinase plasminogen activator and tissue-type plasminogen activator (uPA/tPA) and their major phsyiological inhibitor, plasminogen activator inhibitor-1 (PAI-1; serine protease inhibitor clade E member 1 [SERPINE1]), are upregulated in several cell types during injury repair. Coordinate expression of proteolytic enzymes and their inhibitors in the wound bed provides a mechanism for fine control of focal proteolysis to facilitate matrix restructuring and cell motility in complex environments. Critical Issues: Cosmetic and tissue functional consequences of wound repair anomalies affect the quality of life of millions of patients in the United States alone. The development of novel therapeutics to manage individuals most affected by healing anomalies will likely derive from the identification of critical, translationally accessible, control elements in the wound site microenvironment. Future Directions: Activation of the PAI-1 gene early after wounding, its prominence in the repair transcriptome and varied functions suggest a key role in the global cutaneous injury response program. Targeting PAI-1 gene expression and/or PAI-1 function with molecular genetic constructs, neutralizing antibodies or small molecule inhibitors may provide a novel, therapeutically relevant approach, to manage the pathophysiology of wound healing disorders associated with deficient or excessive PAI-1 levels.

Entities:  

Year:  2014        PMID: 24669362      PMCID: PMC3955966          DOI: 10.1089/wound.2013.0512

Source DB:  PubMed          Journal:  Adv Wound Care (New Rochelle)        ISSN: 2162-1918            Impact factor:   4.730


  61 in total

1.  Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin.

Authors:  D A Waltz; L R Natkin; R M Fujita; Y Wei; H A Chapman
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

3.  Fate of human keratinocytes during reepithelialization in an organotypic culture model.

Authors:  J A Garlick; L B Taichman
Journal:  Lab Invest       Date:  1994-06       Impact factor: 5.662

4.  Therapeutic value of small molecule inhibitor to plasminogen activator inhibitor-1 for lung fibrosis.

Authors:  Wen-Tan Huang; Praveen K Vayalil; Toshio Miyata; James Hagood; Rui-Ming Liu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-01       Impact factor: 6.914

Review 5.  uPAR-uPA-PAI-1 interactions and signaling: a vascular biologist's view.

Authors:  Bernd R Binder; Judit Mihaly; Gerald W Prager
Journal:  Thromb Haemost       Date:  2007-03       Impact factor: 5.249

6.  Vitronectin inhibits plasminogen activator inhibitor-1-induced signalling and chemotaxis by blocking plasminogen activator inhibitor-1 binding to the low-density lipoprotein receptor-related protein.

Authors:  Yuichi Kamikubo; Jaap G Neels; Bernard Degryse
Journal:  Int J Biochem Cell Biol       Date:  2008-07-25       Impact factor: 5.085

7.  PAI-1 expression is required for epithelial cell migration in two distinct phases of in vitro wound repair.

Authors:  Kirwin M Providence; Paul J Higgins
Journal:  J Cell Physiol       Date:  2004-08       Impact factor: 6.384

8.  Integrin expression in the dermis during scar formation in humans.

Authors:  Bartlomiej H Noszczyk; Eberhard Klein; Olaf Holtkoetter; Thomas Krieg; Slawomir Majewski
Journal:  Exp Dermatol       Date:  2002-08       Impact factor: 3.960

9.  Impaired wound healing in mice with a disrupted plasminogen gene.

Authors:  J Romer; T H Bugge; C Pyke; L R Lund; M J Flick; J L Degen; K Dano
Journal:  Nat Med       Date:  1996-03       Impact factor: 53.440

10.  PAI-1 is a Critical Upstream Regulator of the TGF-beta1/EGF-Induced Invasive Phenotype in Mutant p53 Human Cutaneous Squamous Cell Carcinoma.

Authors:  Cynthia E Wilkins-Port; Craig E Higgins; Jennifer Freytag; Stephen P Higgins; J Andrew Carlson; Paul J Higgins
Journal:  J Biomed Biotechnol       Date:  2007-03-20
View more
  31 in total

1.  Transcription and microRNA Profiling of Cultured Human Tympanic Membrane Epidermal Keratinocytes.

Authors:  Peder Aabel; Tor Paaske Utheim; Ole Kristoffer Olstad; Helge Rask-Andersen; Rodney James Dilley; Magnus von Unge
Journal:  J Assoc Res Otolaryngol       Date:  2018-04-05

2.  Cell-specific expression of the transcriptional regulator RHAMM provides a timing mechanism that controls appropriate wound re-epithelialization.

Authors:  Cornelia Tolg; Muhan Liu; Katelyn Cousteils; Patrick Telmer; Khandakar Alam; Jenny Ma; Leslie Mendina; James B McCarthy; Vincent L Morris; Eva A Turley
Journal:  J Biol Chem       Date:  2020-03-12       Impact factor: 5.157

3.  A microRNA-mRNA expression network during oral siphon regeneration in Ciona.

Authors:  Elijah J Spina; Elmer Guzman; Hongjun Zhou; Kenneth S Kosik; William C Smith
Journal:  Development       Date:  2017-04-21       Impact factor: 6.868

4.  Promotion of Wound Healing by an Agonist of Adenosine A2A Receptor Is Dependent on Tissue Plasminogen Activator.

Authors:  M Carmen Montesinos; Avani Desai-Merchant; Bruce N Cronstein
Journal:  Inflammation       Date:  2015-12       Impact factor: 4.092

5.  Aryl Hydrocarbon Receptor Mediates Larval Zebrafish Fin Duplication Following Exposure to Benzofluoranthenes.

Authors:  Michael A Garland; Mitra C Geier; Sean M Bugel; Prarthana Shankar; Cheryl L Dunham; Joseph M Brown; Susan C Tilton; Robyn L Tanguay
Journal:  Toxicol Sci       Date:  2020-07-01       Impact factor: 4.849

6.  Keratin 14-high subpopulation mediates lung cancer metastasis potentially through Gkn1 upregulation.

Authors:  Shun Yao; Hsin-Yi Huang; Xiangkun Han; Yi Ye; Zhen Qin; Gaoxiang Zhao; Fuming Li; Guohong Hu; Liang Hu; Hongbin Ji
Journal:  Oncogene       Date:  2019-07-18       Impact factor: 9.867

7.  Targeted Inhibition of PAI-1 Activity Impairs Epithelial Migration and Wound Closure Following Cutaneous Injury.

Authors:  Tessa M Simone; Whitney M Longmate; Brian K Law; Paul J Higgins
Journal:  Adv Wound Care (New Rochelle)       Date:  2015-06-01       Impact factor: 4.730

8.  High GPX1 expression promotes esophageal squamous cell carcinoma invasion, migration, proliferation and cisplatin-resistance but can be reduced by vitamin D.

Authors:  Xiangfeng Gan; Baishen Chen; Zhuojian Shen; Yeqing Liu; Haifeng Li; Xuan Xie; Xia Xu; Haigang Li; Zhiquan Huang; Ju Chen
Journal:  Int J Clin Exp Med       Date:  2014-09-15

9.  Lymphotoxin-β receptor-NIK signaling induces alternative RELB/NF-κB2 activation to promote metastatic gene expression and cell migration in head and neck cancer.

Authors:  Rita Das; Jamie Coupar; Paul E Clavijo; Anthony Saleh; Tsu-Fan Cheng; Xinping Yang; Jianhong Chen; Carter Van Waes; Zhong Chen
Journal:  Mol Carcinog       Date:  2018-11-28       Impact factor: 4.784

10.  GRHL2 suppresses tumor metastasis via regulation of transcriptional activity of RhoG in non-small cell lung cancer.

Authors:  Xiang Pan; Rong Zhang; Caifeng Xie; Mingxi Gan; Sheng Yao; Yubin Yao; Jiangbo Jin; Tianyu Han; Yunhe Huang; Yanlong Gong; Jianbin Wang; Bentong Yu
Journal:  Am J Transl Res       Date:  2017-09-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.